Anne-Marie Koop

5 217 REFERENCES 1. Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, Buchhorn R. Incidence and Risk Distribution of Heart Failure in Adolescents and AdultsWith Congenital Heart Disease After Cardiac Surgery. Am J Cardiol 2006;97:1238–1243. 2. Borgdorff MAJ, Koop AMC, Bloks VW, Dickinson MG, Steendijk P, Sillje HHW, Wiechen MPH van, Berger RMF, Bartelds B. Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction. J Mol Cell Cardiol Elsevier Ltd; 2015;79:244–253. 3. Koop AMC, Hagdorn QAJ, Bossers GPL, Leusden T van, Gerding A, Weeghel M van, Vaz FM, Koonen DPY, Silljé HHW, Berger RMF, Bartelds B. Right ventricular pressure overload alters cardiac lipid composition. Int J Cardiol Elsevier B.V.; 2019; 4. Faber MJ, Dalinghaus M, Lankhuizen IM, Steendijk P, Hop WC, Schoemaker RG, Duncker DJ, Lamers JM, Helbing WA. Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Hear Circ Physiol 2006;291:H1580-6. 5. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951–1960. 6. Samson N, Paulin R. Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension. Pulm Circ 2017;7:572–587. 7. Rumsey WL, Abbott B, Bertelsen D, Mallamaci M, Hagan K, Nelson D, Erecinska M. Adaptation to hypoxia alters energy metabolism in rat heart. Am J Physiol - Hear Circ Physiol W.L. Rumsey, Zeneca Pharmaceuticals, Wilmington, DE 19850-5437, United States; 1999;276:H71–H80. 8. Drozd K, Ahmadi A, Deng Y, Jiang B, Petryk J, Thorn S, Stewart D, Beanlands R, DeKemp RA, DaSilva JN, Mielniczuk LM. Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension. J Nucl Cardiol L.M. Mielniczuk, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada; 2016;1–11. 9. Gomez-Arroyo J, Mizuno S, Szczepanek K, Tassell B Van, Natarajan R, Remedios CG Dos, Drake JI, Farkas L, Kraskauskas D, Wijesinghe DS, Chalfant CE, Bigbee J, Abbate A, Lesnefsky EJ, Bogaard HJ, Voelkel NF. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Hear Fail N.F. Voelkel, Victoria Johnson Center for Lung Obstructive Disease Research, Virginia Commonwealth University, Richmond, VA 23298, United States; 2013;6:136–144. 10. Bruns DR, Dale Brown R, Stenmark KR, Buttrick PM, Walker LA. Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction. Am J Physiol - Lung Cell Mol Physiol L.A. Walker, Univ. of Colorado-Denver, Dept. of Medicine, Cardiology, Aurora, United States; 2015;308:L158–L167. 11. ZhangW-H, Qiu M-H, Wang X-J, Sun K, Zheng Y, Jing Z-C. Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension. Respir Res Y. Zheng, FirstHospitalofJilinUniversity,CenterofCardiovascularDisease,Changchun,China;2014;15.